<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu J</submitter><funding>Sanming Project of Medicine in Shen-zhen</funding><funding>Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province</funding><funding>Ningbo Science and Technology</funding><funding>Ningbo Science and Technology Project</funding><funding>Ningbo Health Branding Subject Fund</funding><funding>National Social Science Foundation</funding><pagination>1108-1119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7970729</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(4)</volume><pubmed_abstract>&lt;h4>Study question&lt;/h4>What is the current burden of polycystic ovary syndrome (PCOS) at the global, regional, and country-specific levels in 194 countries and territories according to age and socio-demographic index (SDI)?&lt;h4>Summary answer&lt;/h4>Slight increases in age-standardized incidence of PCOS and associated disability-adjusted life-years (DALYs) were evidenced among women of reproductive age (15-49 years) from 2007 to 2017 at the global level, and in most regions and countries.&lt;h4>What is known already&lt;/h4>No detailed quantitative estimates of the PCOS incidence and DALYs by age and SDI in these 194 countries and territories have been published previously.&lt;h4>Study design, size, duration&lt;/h4>An age- and SDI-stratified systematic analysis of the PCOS incidence and DALYs across 194 co</pubmed_abstract><journal>Human reproduction (Oxford, England)</journal><pubmed_title>Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.</pubmed_title><pmcid>PMC7970729</pmcid><funding_grant_id>SZSM201803080</funding_grant_id><funding_grant_id>PPXK2018-02</funding_grant_id><funding_grant_id>19AZD013</funding_grant_id><funding_grant_id>202002N3152</funding_grant_id><funding_grant_id>2021422878</funding_grant_id><pubmed_authors>Jiao M</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Han L</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Jiang S</pubmed_authors><pubmed_authors>Hao Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.</name><description>&lt;h4>Study question&lt;/h4>What is the current burden of polycystic ovary syndrome (PCOS) at the global, regional, and country-specific levels in 194 countries and territories according to age and socio-demographic index (SDI)?&lt;h4>Summary answer&lt;/h4>Slight increases in age-standardized incidence of PCOS and associated disability-adjusted life-years (DALYs) were evidenced among women of reproductive age (15-49 years) from 2007 to 2017 at the global level, and in most regions and countries.&lt;h4>What is known already&lt;/h4>No detailed quantitative estimates of the PCOS incidence and DALYs by age and SDI in these 194 countries and territories have been published previously.&lt;h4>Study design, size, duration&lt;/h4>An age- and SDI-stratified systematic analysis of the PCOS incidence and DALYs across 194 co</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-03T10:10:35.311Z</modification><creation>2025-04-05T19:13:03.478Z</creation></dates><accession>S-EPMC7970729</accession><cross_references><pubmed>33501984</pubmed><doi>10.1093/humrep/deaa371</doi></cross_references></HashMap>